Jhe-Cyuan Guo

6PUBLICATIONS
19CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2026
Site-specific differences in Nectin-4 expression and associated immune contexture in advanced urothelial carcinoma: implications for Nectin-4-targeted ADCs.

|Mar 21, 2026
Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.

Ta-Chen Huang, Jhe-Cyuan Guo, Chia-Chi Lin

|Nov 10, 2025
Does chemotherapy regimen matter for first-line immunochemotherapy in low PD-L1-expressing esophageal squamous cell carcinoma? A systemic review and meta-analysis.

Jhe-Cyuan Guo, Pei-Shan Lin, Wen-Yi Shau

|Jun 21, 2023
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer.

Jhe-Cyuan Guo, Chia-Lang Hsu, Min-Shu Hsieh

|Sep 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma.

Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong

|Jul 11, 2022
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma.

Jhe-Cyuan Guo, Chia-Chi Lin, Chia-Lang Hsu

Pageof 1

Frequent Collaborators

4 joint publications

Chih-Hung Hsu

2 joint publications

Chia-Lang Hsu

2 joint publications

Chien-Huai Chuang

1 joint publications

Tom Wei-Wu Chen